The Long Investor
patreon
The LIT Sunday News
🕑 Added 2025-01-19 15:55:30 +0000 UTCWhite House Chip Export Limits Face Industry Pushback
The White House imposed AI chip export limits, restricting sales to 18 allied nations. Other countries face a cap of 50,000 GPUs annually to enhance security and safeguard U.S. technology.
Market Impact
Nvidia and AMD stocks fell 3% and 4.76%, respectively, following the announcement. The market remains wary of broader economic implications.
Industry Criticism
Nvidia: Ned Finkle criticized the rules as rushed and harmful to U.S. innovation.
Oracle: Ken Glueck warned of an 80% reduction in the global chip market for U.S. firms, with severe effects on the cloud industry.
Key Takeaway
Critics argue the restrictions could stifle U.S. tech dominance, while supporters see them as vital for national security. The 120-day implementation delay offers time for further debate.
China’s Record Trade Surplus Sparks Global Tensions
China’s trade surplus surged to a historic $992bn in 2024, driven by a sharp rise in exports. Over a third of the surplus came from trade with the U.S., heightening tensions just as Donald Trump prepares to begin his second term as U.S. president. Trump has pledged to impose tariffs of up to 60% on Chinese goods and a blanket 20% tariff on all U.S. trading partners, which could significantly disrupt global trade.
Export Surge and Trade Imbalance
China’s exports grew due to “front-loading,” as producers expedited shipments before the anticipated tariffs. The December trade surplus reached $104.8bn, a monthly record, with exports increasing 10.7% year-on-year. Imports, by contrast, grew by only 1%.
Tariff Strategy and Economic Shifts
Trump’s aggressive tariff strategy aims to reduce U.S. reliance on Chinese imports and address the trade imbalance. However, analysts warn that such measures could backfire, straining global supply chains and increasing costs for U.S. consumers. Chinese producers have responded by boosting exports to offset sluggish domestic demand, further deepening trade tensions.
Shifts in Trade Patterns
While the U.S. remains a key market, its share of Chinese exports dropped slightly to 14.7%, as exports to Southeast Asia rose to 16.4%. Chinese manufacturers are diversifying production to avoid tariffs, strengthening ties with regional partners.
Economic and Policy Challenges
Economists caution that the export boost may fade as tariffs take hold, compounding pressure on domestic demand weakened by a property slump. More policy support will likely be needed to sustain economic growth.
Broader Implications
China’s rise as a green-energy leader and top car exporter highlights its evolving global role. However, escalating trade tensions and possible U.S. measures targeting rerouted exports could create significant obstacles for China’s economy and its trading partners.
No One Is Talking About a Recession, but Red Flags Remain
Key Red Flags to Watch
Jobs and Inflation
Low unemployment remains, but inflation could erode real incomes and consumer confidence.
Slowing immigration and natural labor market limits may constrain further growth.
Trump Administration Policies
Proposed tariffs and reduced immigration could cut GDP growth by 1.25% in 2025 (NIESR estimate).
Cuts to government spending may remove safety nets during economic downturns.
Populist policies might increase inflation and disrupt markets.
Market and Economic Disconnect
Stock market and economic performance often diverge.
Goldman Sachs predicts a "lost decade" for stocks with real annual returns under 3%.
Yield Curve and Overconfidence
The inverted yield curve, a traditional recession signal, normalized in late 2024.
Despite improved sentiment, overconfidence in sustained growth could blind markets to risks.
The Bottom Line
While no major institution predicts a recession in 2025, risks like policy changes, market corrections, and structural economic limits highlight the need for caution. Investors must remain vigilant in a climate where traditional risk assessments may be distorted.
Porsche Struggles in China Amid Intensifying Competition
Porsche has reported a significant 28% drop in deliveries to Chinese customers in 2024, selling 56,887 vehicles compared to the previous year. This decline, attributed to a "challenging economic situation," offset growth in other regions and contributed to a 3% decrease in total global deliveries, which stood at 310,718.
The slump in the world’s largest car market comes at a crucial time for Porsche’s parent company, Volkswagen (VW), which faces shrinking demand in Europe and underwhelming sales of its electric vehicles. VW’s flagship brand saw an 8.3% drop in Chinese deliveries in 2024, losing ground to domestic EV competitors like BYD, Xpeng, and Geely.
Despite a 5.5% growth in China’s automotive market, rising competition has intensified concerns for VW, whose shareholders worry about declining market leadership. Porsche’s management remains focused on profit margins, refusing to engage in a price war and reaffirming its commitment to a “value-based sales approach.”
Johnson & Johnson Makes $14.6 Billion Bet on Mental Health with Intra-Cellular Acquisition
Johnson & Johnson has agreed to acquire biotech firm Intra-Cellular Therapies in a $14.6 billion deal, marking the largest biotech acquisition in over a year. The company will pay $132 per share in cash, with the deal expected to close later in 2025.
Focus on Mental Health
Intra-Cellular specializes in treatments for mental health and neurological disorders. Its flagship product, Caplyta, is an oral therapy for schizophrenia and bipolar-related depressive episodes. The company has also applied to expand Caplyta’s FDA label to include major depressive disorder (MDD), a condition affecting 21 million U.S. adults annually.
Market Reaction and Strategic Outlook
Shares of Intra-Cellular surged 36% to $128.75 in premarket trading, while J&J shares remained flat. CEO Joaquin Duato described the acquisition as a key growth catalyst for the company’s portfolio. Analysts view this move as a potential boost for the struggling healthcare sector, which has underperformed the S&P 500 in recent years.
Broader Implications for Biopharma
The announcement aligns with the J.P. Morgan Healthcare Conference, where Intra-Cellular’s CEO is set to present. Analysts predict more biopharma mergers in 2025, supported by a potentially lighter regulatory environment under the incoming Trump administration. Johnson & Johnson will provide updates on the deal’s impact during its Jan. 22 earnings guidance.
Arm Plans Price Hikes and Considers Chip-Making, Sparking Customer Concerns
Arm Holdings, a major supplier of chip technology, is developing plans to increase royalty rates by up to 300% and potentially enter the chip-making market. The company aims to boost annual revenue by $1 billion over the next decade through these changes. Known internally as the "Picasso" project, the strategy includes higher per-chip royalties for its latest architecture, Armv9.
Competitive Landscape
Arm licenses intellectual property used by companies like Apple, Qualcomm, and Microsoft to design their own chips. However, large customers often bypass Arm’s pricier ready-made designs, reducing the impact of the planned rate hikes.
Chip-Making Ambitions
Arm has also discussed designing its own chips, a shift that could challenge its existing customers. CEO Rene Haas suggested in internal communications that entering the chip market could disrupt companies like Qualcomm. Analysts warn such a move could alienate Arm’s client base, creating significant risks for the firm.
SoftBank's Role and Market Expansion
Since SoftBank acquired Arm in 2016, the company has expanded beyond smartphones into PCs and data centers. These new markets could support Arm’s ambitions, but they also place it in direct competition with established players like AMD and Intel.
Customer Backlash
The potential for higher royalties and competition from Arm itself has caused unease among clients. Arm’s CEO emphasized that these strategies are exploratory and part of long-term planning. However, experts note that such moves could reshape relationships within the chip industry, with potential consequences for Arm’s market position.
Beijing and London to Explore UK-China Financial Linkages
New Economic Cooperation Initiatives
The UK and China have agreed to study the feasibility of creating exchange-traded fund (ETF) and wealth management connect schemes. The announcement follows UK Chancellor Rachel Reeves’ visit to Beijing, during which both sides committed to strengthening financial ties and deepening cooperation in wealth management.
Plans also include enhancing the UK-China Stock Connect and launching a UK-China over-the-counter bond business. The UK welcomed recent Chinese licences and quotas granted to companies like HSBC, Schroders, and Aspect Capital.
Progress in Capital Market Integration
China and the UK aim to improve cross-border capital flows, including increasing ETF listings in London by Chinese asset managers. Reeves highlighted London as a “natural home” for Chinese financial services to raise capital and expand globally.
China’s vice-premier He Lifeng announced plans for a renminbi-denominated sovereign green bond in 2025 and encouraged qualified UK banks to join China’s renminbi cross-border payment system.
Joint Task Force for Market Reforms
A new task force, comprising FTSE Russell, the Shanghai Stock Exchange, and the Shenzhen Stock Exchange, will work to support China’s capital market reforms and attract international investors. The initiative will also facilitate consultations on UK fund managers’ services in China, aligning with domestic regulations.
Broader Global Implications
The announcement reflects China’s efforts to expand ETF link-ups globally, with existing agreements in Hong Kong and Singapore and ongoing talks with Saudi Arabia and other nations. These developments are part of broader efforts to promote cross-border investing and deepen financial ties between China and its global partners.
Capital One Faces $2 Billion Lawsuit Over Savings Account Practices
Allegations of Misconduct
The Consumer Financial Protection Bureau (CFPB) has filed a lawsuit against Capital One Financial Corp., accusing the bank of withholding information about higher-yielding savings accounts. The CFPB claims Capital One misled customers who signed up for its 360 Savings program by not informing them about the newer 360 Performance Savings account, which offered up to 14 times more interest.
From 2019 to 2024, Capital One reduced the 360 Savings interest rate to 0.3%, while raising the 360 Performance Savings rate to 4.35% by January 2024.
Legal and Market Implications
Capital One denies the allegations, calling the lawsuit a politically motivated move before the change in administration. Analysts, however, do not expect the lawsuit to impact the bank’s $35 billion merger with Discover Financial Services.
The CFPB seeks to compensate affected customers and impose civil penalties. Some analysts suggest the lawsuit could be dropped under the incoming Trump administration, though others argue Trump’s populist stance might support the CFPB’s case.
Broader Repercussions
Critics argue that Capital One prioritized profits over customer loyalty by keeping higher interest rates from existing account holders. Consumer advocates have praised the CFPB’s efforts, highlighting its track record of recovering billions for wronged customers.
This lawsuit adds scrutiny to Capital One’s practices as it moves forward with its merger, raising questions about its commitment to community benefits and fair treatment of account holders.
Venture Global Aims for Historic $2.3 Billion LNG IPO Amid Regulatory Uncertainty
Overview of the IPO
Venture Global, a leading U.S. liquefied natural gas (LNG) exporter, is preparing for an IPO that could raise up to $2.3 billion, valuing the company at $110 billion. This would make it the largest U.S. energy IPO in over a decade. The company’s founders, Robert Pender and Michael Sabel, will retain 97% voting control through special Class B shares.
LNG Market and Venture Global’s Position
Venture Global operates two LNG plants and has three more under development. U.S. LNG exports have surged, driven by global demand and Europe’s shift away from Russian gas after the Ukraine invasion. With its projects, Venture Global aims to supply up to 143.8 million tons of LNG annually, potentially using 15%-20% of U.S. natural gas production.
Financial Performance
The company earned $2.7 billion on $7.9 billion in revenue in 2023, though it trails Cheniere Energy, the largest U.S. LNG provider, which earned $10 billion on $20 billion in revenue the same year. Venture Global plans to use a vertically integrated model, owning pipelines and ships alongside its LNG facilities, while leveraging cash flows from existing projects to fund new developments.
Challenges and Risks
Venture Global faces regulatory and market hurdles. Analysts predict an oversupplied LNG market by 2026, potentially reducing prices in Europe by 30%. Environmental concerns over natural gas emissions and construction delays also pose risks.
Regulatory uncertainty looms as well. The Biden administration paused LNG project approvals in 2024, and while Trump’s incoming administration is expected to lift the freeze, there’s no guarantee of immediate action.
Future Outlook
If Venture Global successfully navigates permitting challenges and maintains strong LNG demand, it could solidify its position as a behemoth in the global LNG market. However, oversupply risks and environmental scrutiny will likely shape its trajectory in the coming years.
GM Signs Major Deal to Lower EV Battery Costs
General Motors has secured a multibillion-dollar deal with Norwegian firm Vianode to source synthetic anode graphite, a critical lithium-ion battery component. Production will begin in 2027 at a new North American plant.
Focus on EV Profitability
The deal supports GM’s joint venture with LG Energy Solution, Ultium Cells, which has reduced costs through vertical integration and efficient production. CEO Mary Barra highlighted benefits from falling commodity prices and advanced manufacturing.
Market Alignment
With declining EV battery costs and increasing demand for sustainable energy, GM is strategically positioned to enhance profitability and compete in the growing EV market.
This streamlined agreement reflects GM’s urgency to make EVs cost-effective while leveraging innovations in battery technology.
Outgoing FDA Chief Warns of Online Weight Loss Drug Risks
FDA Commissioner Robert Califf, in his final remarks before stepping down, highlighted the dangers of compounded weight loss drugs sold online. These lower-cost versions of Novo Nordisk and Eli Lilly products, priced in the hundreds compared to over $1,000 for the originals, pose risks due to inconsistent quality and unclear safety standards.
Regulatory Gaps
Califf criticized current laws as insufficient to protect consumers from the growing online market of compounded medications. He noted that high prices of the original drugs drive demand for cheaper alternatives, exacerbating the problem.
FDA Challenges Ahead
Califf called for stronger FDA support, contrasting with President-elect Donald Trump’s nominee for health secretary, Robert F. Kennedy Jr., who has proposed cutting parts of the FDA. Califf warned that underfunding critical areas, such as food and drug safety, could further compromise public health.
As he prepares to leave his role, Califf’s remarks underline the need for stronger oversight to address emerging health risks in the U.S. market.
GAC Awaits Approval for First Battery Swap-Compatible EV
GAC Group, a Chinese automaker, has announced that it is awaiting internal approval to develop its first electric vehicle (EV) compatible with Nio’s battery swap technology. This partnership stems from a 2024 agreement between the companies to collaborate on charging and battery-swapping services.
Technical Readiness
GAC’s Director of Battery System Integration, Qingquan Wang, stated that the company has completed "technical alignments," requiring only minor modifications to some of its car models for compatibility. However, no timeline has been provided for the launch of the battery swap-compatible models.
Battery Swap Technology
Nio’s fourth-generation battery swap stations enable drivers to replace a depleted battery with one charged to 90–95% in about three minutes. With over 3,000 stations in China and 60 in Europe, Nio is expanding its battery swap ecosystem.
European Expansion
GAC plans to enter the European market later this year, beginning in Portugal, Poland, and Norway, using lithium iron phosphate (LFP) batteries. The company has already started testing vehicles shipped from Guangzhou.
Broader Market Context
In 2024, GAC’s sales dropped by 20% to just over 2 million units, including its joint ventures with Toyota and Honda. Nio has also been upgrading its battery swap stations to support both its primary vehicles and its second brand, Onvo.
This partnership highlights the growing adoption of battery swap technology in the EV industry and GAC’s strategic move to align with Nio’s extensive infrastructure.
Richemont Leads Luxury Sector Surge with Record Sales
Richemont, owner of Cartier and Montblanc, reported a 10% rise in fiscal Q3 sales to €6.15 billion, smashing analysts’ expectations of 1% growth. While sales in China, Hong Kong, and Macau dropped 18%, robust demand from South Korea, North America, the Middle East, and Europe offset the decline. European sales surged 19%, driven by both domestic demand and tourism.
Product Performance
Jewelry sales jumped 14%, compensating for an 8% decline in watches. The results highlight Richemont’s ability to adapt to shifting demand dynamics within the luxury market.
Market Reaction
Richemont’s Swiss-listed shares soared 18%, marking their best trading day on record. The news lifted other luxury stocks, with gains for Swatch, Moncler, Hermes, and LVMH, as well as a 4% rise in the Amundi S&P Global Luxury UCITS ETF.
Industry Insights
Deutsche Bank analysts noted that premium luxury brands are likely to outperform, citing strong global demand outside China. Bank of America upgraded Richemont, LVMH, and Zegna to "buy," while downgrading Brunello Cucinelli and Watches of Switzerland due to concerns about prolonged recovery in China and reduced brand engagement.
Outlook
The luxury sector faces cyclical challenges, particularly in China, but global demand and cost control measures have helped sustain growth. Richemont’s record-breaking quarter underscores resilience among premium brands, even amid regional economic headwinds.
eToro Files for U.S. IPO, Seeks $5 Billion Valuation
Retail trading platform eToro has confidentially filed with U.S. regulators for an initial public offering (IPO) in New York, targeting a valuation exceeding $5 billion. The Israeli-founded company, whose largest market is the UK, aims to leverage the deeper liquidity and broader investor base of the U.S. market.
Chief Executive Yoni Assia explained the choice, noting that few of eToro’s global clients trade UK shares and that a U.S. listing offers better visibility and investor access.
Background and Market Context
Founded in 2007, eToro enables trading of assets like stocks and cryptocurrencies. As of March 2023, it managed $11.3 billion across 3 million accounts. Its IPO plans follow a challenging previous attempt in 2021 via a $10.4 billion SPAC deal, which collapsed in 2022 due to market conditions.
After a funding round in 2023 valued eToro at $3.5 billion, the company now hopes to surpass that significantly with its U.S. flotation, potentially occurring as soon as Q2 2025.
Broader Implications
eToro’s decision highlights the ongoing struggle of the London IPO market to attract high-profile listings. The platform’s move adds to a trend of start-ups opting to stay private longer or listing in U.S. markets for better opportunities.
Investment banks including Goldman Sachs, Jefferies, and UBS are advising eToro on its IPO, though none of the parties has commented publicly on the plans.
Nathan Anderson Shuts Down Hindenburg Research, Citing Intensity of Activist Short Selling
Nathan Anderson, the prominent activist short seller behind Hindenburg Research, announced the closure of his firm seven years after founding it. Known for targeting companies like Adani Group, Nikola, and Super Micro, Anderson cited the demanding nature of the job as the main reason for stepping away.
“The plan has been to wind up after finishing the pipeline of ideas,” Anderson said in a statement. He reflected on the sacrifices involved, noting, “It has come at the cost of missing a lot of the rest of the world and the people I care about.”
Legacy and Impact
Hindenburg Research gained fame for its detailed investigations into corporate fraud and misconduct. Its reports led to fraud charges against dozens of individuals, including the high-profile case against Nikola’s founder Trevor Milton, who was convicted of fraud. The firm’s unconventional methods, such as secretly recording a suspected Ponzi scheme pitch, often drew attention.
Hindenburg’s small team of 11 employees consistently tackled high-profile targets, including activist investor Carl Icahn, whose company’s shares fell 20% after a 2023 report. Despite its success, the firm faced significant legal battles and industry challenges, contributing to Anderson’s decision to step back.
Decline of Activist Short Selling
The closure of Hindenburg highlights broader struggles within the activist short-selling industry. Major figures like Jim Chanos and Bill Ackman have also scaled back or exited the field in recent years, citing market challenges such as passive investment growth and regulatory scrutiny.
A Unique Farewell
Anderson’s final message included a personal note and a link to a DJ set played in Bali, which he credited with having a profound impact during a pivotal time in his life. Hindenburg’s last report focused on online car retailer Carvana, marking the end of an era for one of Wall Street’s most controversial and influential short sellers.
Nio Expected to Join Hong Kong’s Hang Seng Index, Says CICC
Chinese EV maker Nio (NYSE: NIO, HKG: 9866) is anticipated to be included in the Hang Seng Index (HSI), a move that could attract passive investment inflows, according to a report by Chinese brokerage CICC.
The HSI’s semi-annual review results will be announced on February 21, with adjustments taking effect on March 10. Nio’s potential inclusion reflects its market capitalization and industry standing, although past forecasts for companies like JD Logistics and Innovent Bio have proven uncertain.
Market Context
ETFs and Passive Funds: ETFs tracking the Hang Seng Index hold approximately $27.53 billion in assets, while those tracking the Hang Seng China Enterprises Index and Hang Seng Tech Index hold $5.41 billion and $18.66 billion, respectively.
Nio's Current Position: Since 2022, Nio has been part of the Hang Seng Composite Index and Hang Seng Technology Index, following its secondary listing in Hong Kong.
Stock Performance
Despite its weak performance in 2024, with a 53% decline in Hong Kong shares, Nio’s inclusion in a major index could bolster its market visibility. By contrast, the Hang Seng Index and Hang Seng Composite Index gained 18% and 16%, respectively, during the same period.
Significance of the Hang Seng Index
As Hong Kong’s oldest and most important stock market index, launched in 1969, the Hang Seng Index serves as a key measure of the market’s performance. Inclusion in this flagship index would mark a significant milestone for Nio, enhancing its appeal to investors globally.
The final decision on Nio’s inclusion, along with other potential entrants like JD Logistics and Innovent Bio, will underscore the impact of passive fund flows on the Hong Kong market.
UnitedHealth Faces Revenue Miss, Rising Costs, and Criticism Over Drug Prices
UnitedHealth Group missed quarterly revenue expectations for the first time in over four years, reporting $100.81 billion compared to the expected $101.60 billion. Despite a 6.8% year-over-year revenue increase, medical costs rose 7.7%, contributing to a higher-than-expected medical-loss ratio of 85.5%.
Net income rose slightly to $5.54 billion, with adjusted earnings per share (EPS) of $6.81 beating expectations of $6.73. However, operating costs climbed 7.3%, driven by a 22.3% increase in product costs and a rise in medical expenses.
CEO Defends PBMs Amid Drug Pricing Backlash
Amid scrutiny of pharmacy-benefit managers (PBMs), CEO Andrew Witty argued that companies like UnitedHealth’s Optum Rx help lower drug costs. He highlighted that Optum Rx passed through more than 98% of drug rebates in 2024 and aims for 100% by 2028. Witty redirected blame for high drug prices to manufacturers, citing examples of U.S. drug costs being disproportionately higher than in Europe.
Outlook and Challenges
Cost Pressures: Rising utilization rates and specialty medication prescriptions are expected to keep costs elevated into 2025.
Revenue Guidance: UnitedHealth forecasts 2025 revenue between $450 billion and $455 billion, with adjusted EPS of $29.50 to $30.00.
Policy Adjustments: Witty pledged improvements in insurance processes, including reducing prior authorizations and streamlining approvals for Medicare Advantage patients.
Broader Context
While UnitedHealth has consistently beaten profit expectations, rising medical costs and missed revenue targets signal growing challenges. The company remains under pressure to balance healthcare costs, policy demands, and investor expectations.
Bank of America Posts Strong Q4 Results, Sets Positive Tone for 2025
Bank of America (BoA) reported robust Q4 results, with revenue rising 15% year-over-year to $25.3 billion, surpassing analyst expectations of $25.1 billion. Net income more than doubled to $6.4 billion from $2.84 billion a year earlier, while adjusted earnings per share (EPS) hit $0.82, beating the consensus of $0.77.
Net interest income (NII) increased 3% year-over-year to $14.5 billion, driven by higher loan balances, deposit growth, and fixed-rate asset repricing.
Broad Momentum Across Divisions
CEO Brian Moynihan highlighted gains across all business units, including:
Consumer Banking: Revenue rose 3% to $10.6 billion, with 213,000 new checking accounts added.
Investment Banking: Fees surged 44% to $1.7 billion, bolstered by growing M&A confidence.
Sales and Trading: Revenue climbed 13% to $4.1 billion, marking the 11th consecutive quarter of growth.
Asset Management: Revenue increased 15% to $6 billion, driven by a 23% rise in fees.
Operational Efficiency and Tailwinds
Operating expenses fell 16% to $16.8 billion, reflecting cost savings and the absence of a special assessment tied to the Silicon Valley Bank collapse. BoA also replaced maturing lower-interest securities with higher-yielding assets, improving returns.
Optimistic 2025 Outlook
BoA expects Q1 NII of $14.5–$14.6 billion and Q4 NII of $15.5–$15.7 billion, both exceeding analyst estimates. Corporate clients are showing renewed optimism in M&A activity, while stable credit conditions and advancements in AI adoption present additional growth opportunities.
Market and Analyst Reaction
Despite strong results, BoA’s stock dipped 0.8% after rising 3% earlier in the week. Analysts, including those from HSBC and Citi, maintained "buy" ratings, citing solid performance and favorable market conditions.
As BoA enters 2025, its diversified revenue streams, cost management, and bullish outlook position it strongly in a competitive banking environment.
Target’s Holiday Sales Rebound, Boosting Fourth-Quarter Guidance
Target Corp. reported stronger-than-expected holiday sales, with a 2.8% growth in total sales for November and December compared to the prior year. Same-store sales rose 2%, driven by a nearly 3% increase in traffic across online and in-store visits. The retailer achieved record sales during Black Friday and Cyber Monday events, leading it to raise its fourth-quarter same-store sales guidance to 1.5% growth, up from flat expectations.
Key Drivers of Growth
Discretionary Categories: Clothing and toys experienced meaningful sales acceleration.
Digital Sales: Grew 9%, fueled by a 30% increase in same-day delivery via the Target Circle 360 membership program.
In-Store Fulfillment: Over 97% of Target’s sales were fulfilled in stores, reflecting operational efficiency.
Target Plus Marketplace: Saw a 50% increase in growth.
Challenges and Recovery
The update alleviated concerns following Target’s weak third-quarter earnings, which were impacted by supply chain costs, higher inventory levels, and cautious consumer spending amid inflation. Analysts at Jefferies and D.A. Davidson noted that the holiday performance aligns with improving discretionary spending trends.
Executive Changes
Target announced leadership transitions effective February 2:
Mark Schindele (Chief Stores Officer) will retire and be replaced by Adrienne Costanzo.
Brett Craig (Chief Information Officer) will retire, with Prat Vemana taking over as Chief Digital and Product Officer.
Sarah Travis will be promoted to Chief Digital and Revenue Officer.
Outlook
Target reiterated its earnings guidance, expecting fourth-quarter EPS of $1.85–$2.45 and adjusted full-year EPS of $8.30–$8.90. Analysts remain optimistic about the retailer’s ability to sustain momentum, supported by strong traffic and digital growth, positioning it well for 2025.
Comments
Som
This is great!! Really appreciate the efforts going into this. Couple of feedbacks. 1) Can you add a summary note for how the individual news element affects the top 10 2025 and watchlist we are tracking in this group ? 2) Can we add more content relevant to the stocks we keep track on ? Maybe some of these are indirectly relevant or affects the ones we keep track but would be really helpful if we get that context.
Markx0x
Very informative. Thank you Voj, Cap!
Ant
Great Read as Always team! Couple pieces of feedback below. 1) Summarized Key points of the News letter at the top. 2) Maybe this is not possible because it’s on Patreon, but would love the ability to navigate to specific “sections” Thank you Voj and TLI 💰
kenv
Another great recap. IMO, Trump is a deal maker, so they will be made. It’ll swing the market. I’ve been bullish biotech all last year and was flat. Need to add to my Baba apparently now. And I need to accumulate/watch ARM.
Willis
Fantastic, a good Sunday morning coffee read. Feedback: Could use a quick summary section for those that are on a time crunch
khaled rasmy
Really good one, would be great to also add a section about crypto news
Jake Mace
This is fantastic. Thank you Cap
Martechnic
Great summary! This helps me a lot to keep up with companies I'm not actively following myself.
Martechnic
Great. Going to read this in full later this evening 🤝
D M
I was in all the chats. Now I am not. When I try to join them again, I'm prompted with "I agree" button that I can't click. I'm missing all announcement messages
Vojtěch Šimeček
You can join chats when you click at Chats folder right in the TLI home page.
Vojtěch Šimeček
Great, thank you for that🙏🏻
Taylor D
This is great as always, very appreciated. Some feedback, as requested: the depth and length of information here is exhaustive and great. I'd love some kind of executive summary / tl;dr at the top. It could be as simple as pulling all the takeaways from each section to the top. That way, if I'm crunched for time, I can still get the key insights.
D M
Sorry to comment here but I have been kicked out of chats and can't rejoin. I reached out to Patreon support for help days ago but nothing. Any advise? I'm missing everything all week. Only getting charts
Bercan
Legend !great one again
